Pain Management — Medicare Part B billing by state
303 physician groups whose primary specialty is Pain Management billed $165.0M to Medicare fee-for-service in 2023.
Calendar year 2023 · Medicare fee-for-service Part B
You're viewing calendar year 2023. State market links open the latest data year.
On this page: Billing by state · Top codes
Medicare billing by state
| State | Standardized payments | Medicare payments | Groups | Pay / group | Services | Benef.-episodes | Svc / group |
|---|---|---|---|---|---|---|---|
| Florida | $19.5M | $19.4M | 27 | $720K | 484K | 110K | 17,940 |
| California | $17.3M | $18.1M | 40 | $453K | 353K | 82,309 | 8,820 |
| Texas | $13.8M | $13.4M | 31 | $431K | 243K | 78,021 | 7,840 |
| Kentucky | $11.5M | $10.5M | 11 | $959K | 242K | 71,118 | 21,990 |
| Utah | $10.8M | $10.5M | 9 | $1.2M | 663K | 55,726 | 73,667 |
| Arizona | $10.5M | $10.2M | 20 | $509K | 162K | 63,028 | 8,077 |
| Georgia | $6.3M | $6.1M | 9 | $674K | 80,536 | 41,824 | 8,948 |
| Arkansas | $6.1M | $5.7M | 11 | $516K | 74,581 | 34,593 | 6,780 |
| Pennsylvania | $5.6M | $5.7M | 17 | $336K | 97,302 | 35,010 | 5,724 |
| New Jersey | $5.2M | $5.5M | 14 | $391K | 90,222 | 28,594 | 6,444 |
| New York | $4.4M | $4.6M | 20 | $232K | 153K | 30,589 | 7,663 |
| Illinois | $4.2M | $4.2M | 15 | $279K | 112K | 28,572 | 7,449 |
| Tennessee | $4.1M | $3.8M | 10 | $385K | 82,341 | 30,615 | 8,234 |
| Indiana | $4.0M | $3.8M | 4 | $946K | 60,665 | 23,190 | 15,166 |
| Ohio | $3.9M | $3.8M | 13 | $289K | 69,831 | 26,735 | 5,372 |
| Nevada | $3.6M | $3.5M | 13 | $273K | 79,500 | 24,986 | 6,115 |
| Washington | $3.4M | $3.5M | 5 | $691K | 49,854 | 19,364 | 9,971 |
| Oklahoma | $3.4M | $3.2M | 4 | $801K | 132K | 14,220 | 32,981 |
| Delaware | $3.2M | $3.2M | 4 | $798K | 77,064 | 26,346 | 19,266 |
| Nebraska | $3.1M | $2.9M | 5 | $572K | 124K | 21,496 | 24,788 |
| Maryland | $2.4M | $2.5M | 10 | $253K | 48,230 | 16,389 | 4,823 |
| Alabama | $2.3M | $2.1M | 11 | $195K | 49,288 | 17,350 | 4,481 |
| South Carolina | $2.3M | $2.1M | 4 | $529K | 62,880 | 17,409 | 15,720 |
| Michigan | $2.2M | $2.1M | 12 | $174K | 76,333 | 13,122 | 6,361 |
| North Carolina | $1.7M | $1.6M | 8 | $203K | 32,402 | 10,499 | 4,050 |
| Virginia | $1.6M | $1.6M | 6 | $259K | 40,056 | 10,986 | 6,676 |
| Colorado | $1.4M | $1.4M | 5 | $287K | 27,804 | 7,781 | 5,561 |
| Mississippi | $1.3M | $1.3M | 5 | $251K | 22,750 | 9,219 | 4,550 |
| Kansas | $1.3M | $1.2M | 4 | $293K | 31,405 | 7,677 | 7,851 |
| New Mexico | $1.1M | $1.1M | 6 | $176K | 37,804 | 7,424 | 6,301 |
| Louisiana | $1.1M | $1.0M | 7 | $147K | 18,569 | 7,275 | 2,653 |
| Minnesota | $1.1M | $1.0M | 2 | $523K | 13,783 | 6,230 | 6,892 |
| Oregon | $978K | $975K | 4 | $244K | 15,457 | 6,103 | 3,864 |
| Massachusetts | $917K | $929K | 5 | $186K | 14,921 | 5,151 | 2,984 |
| Missouri | $675K | $658K | 2 | $329K | 9,039 | 5,713 | 4,520 |
| Idaho | $651K | $589K | 4 | $147K | 13,540 | 5,037 | 3,385 |
| Wisconsin | $637K | $600K | 2 | $300K | 7,928 | 4,521 | 3,964 |
| New Hampshire | $357K | $348K | 1 | $348K | 4,071 | 2,179 | 4,071 |
| PR | $131K | $131K | 3 | $44K | 1,949 | 1,342 | 650 |
| South Dakota | $109K | $106K | 1 | $106K | 1,472 | 917 | 1,472 |
| Rhode Island | $98K | $96K | 1 | $96K | 1,028 | 399 | 1,028 |
| West Virginia | $28K | $26K | 1 | $26K | 516 | 273 | 516 |
| Vermont | $16K | $16K | 1 | $16K | 864 | 236 | 864 |
| Alaska | $2K | $3K | 1 | $3K | 57 | 56 | 57 |
Need this specialty's market in one document?
Register your interestEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2023
7 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.
| Code | Medicare payments | Services | Largest state markets |
|---|---|---|---|
| G0482 · Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $7.2M | 37,487 | FLCATXKYUT |
| G0483 · Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $4.8M | 19,930 | FLCATXKYUT |
| G0481 · Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $4.5M | 29,670 | FLCATXKYUT |
| J0717 · Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) top by services | $1.4M | 349K | FLCATXKYUT |
| J0585 · Injection, onabotulinumtoxina, 1 unit top by services | $1.0M | 209K | FLCATXKYUT |
| J3262 · Injection, tocilizumab, 1 mg top by services | $463K | 98,800 | FLCATXKYUT |
| J3300 · Injection, triamcinolone acetonide, preservative free, 1 mg top by services | $339K | 104K | FLCATXKYUT |
| J3301 · Injection, triamcinolone acetonide, not otherwise specified, 10 mg top by services | $184K | 222K | FLCATXKYUT |
| Q9966 · Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml top by services | $42K | 124K | FLCATXKYUT |
| J1100 · Injection, dexamethasone sodium phosphate, 1 mg top by services | $35K | 364K | FLCATXKYUT |